4-Methylmorpholine → HCID 22907047、化合物
反応式
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][C:6]([S:9]([N:12]([CH2:29][C:30]2[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=2)[C:13]2([C:26](O)=[O:27])[CH2:18][CH2:17][N:16]([CH2:19][C:20]3[CH:25]=[CH:24][CH:23]=[CH:22][CH:21]=3)[CH2:15][CH2:14]2)(=[O:11])=[O:10])=[CH:5][CH:4]=1.CN1CCOCC1.Cl.[C:44]([O:48][NH2:49])([CH3:47])([CH3:46])[CH3:45].Cl.CN(CCCN=C=NCC)C>C(Cl)Cl.O>[C:44]([O:48][NH:49][C:26]([C:13]1([N:12]([S:9]([C:6]2[CH:7]=[CH:8][C:3]([O:2][CH3:1])=[CH:4][CH:5]=2)(=[O:11])=[O:10])[CH2:29][C:30]2[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=2)[CH2:18][CH2:17][N:16]([CH2:19][C:20]2[CH:21]=[CH:22][CH:23]=[CH:24][CH:25]=2)[CH2:15][CH2:14]1)=[O:27])([CH3:47])([CH3:46])[CH3:45]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
To a mixture of 4-[[4-methoxybenzenesulfonyl](benzyl)amino]-1-[benzyl]-4-[carboxy]-piperidine (850.0 mg, 1.64 mmol) in methylene chloride (100 mL) containing N-methylmorpholine (0.6 ml, 5.48 mmol) and O-t-butylhydroxyl amine hydrochloride (620.0 mg, 4.94 mmol) is added N-[dimethylaminopropyl]-N'-ethylcarbodiimide hydrochloride (1.1 g, 5.74 mmol). The reaction mixture is stirred overnight at room temperature. The mixture is diluted with water and extracted with methylene chloride. The combined organic extracts are dried (Na2SO4) and the solvent is evaporated. The crude product is purified by silica gel chromatography (ethyl acetate) to provide 4-[N-t-butyloxy-carbamoyl]-4-[[4-methoxybenzenesulfonyl](benzyl)amino]-1-[benzyl]-piperidine.
後処理
- extractionextracted with methylene chloride
- dry with materialThe combined organic extracts are dried (Na2SO4)
- customthe solvent is evaporated
- customThe crude product is purified by silica gel chromatography (ethyl acetate)
出典と根拠
- ORDレコード
- ord-bd342527dbab4b268c90f12665dc57c5
- 出典データセット
- uspto-grants-1996_09
- 特許番号
- US05552419
反応ノート
読み込み中…